Market Cap 8.15B
Revenue (ttm) 570.40M
Net Income (ttm) 223.19M
EPS (ttm) N/A
PE Ratio 34.33
Forward PE 38.93
Profit Margin 39.13%
Debt to Equity Ratio 0.00
Volume 2,370,000
Avg Vol 2,549,246
Day's Range N/A - N/A
Shares Out 188.27M
Stochastic %K 93%
Beta 1.39
Analysts Sell
Price Target $67.90

Company Profile

Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants...

Industry: Health Information Services
Sector: Healthcare
Phone: 650 549 4330
Address:
500 3rd Street, Suite 510, San Francisco, United States
StockAnalyst_SA
StockAnalyst_SA Jan. 7 at 9:19 AM
$ONDS – Big Defense Win 🚀 Subscribe for access! It's free 👉 @StockAnalyst_SA (No noise !!) Project: 4M Demining tech part of Israeli MoD multi-layer border system Contract Value: ~$1.7B total Implication: Likely includes Ondas’ recent large border drone order – huge revenue potential ahead $ILMN $ULS $DOCS $AAPL
0 · Reply
11thestate
11thestate Jan. 5 at 2:39 PM
$DOCS has agreed to settle with investors over claims that it misled them by masking declining sales and weaknesses in its healthcare advertising business. Who’s eligible? Anyone who purchased $DOCS shares between July 21, 2021 and August 11, 2022. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? Payout per share has not been determined yet. Can I still file? Claim availability depends on the settlement administrator’s approval process. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/doximity-investor-suit
0 · Reply
SkookBuffett
SkookBuffett Jan. 2 at 5:51 PM
$DOCS may buy back in, question is will it hit a lower low
0 · Reply
TheFedSucks
TheFedSucks Dec. 30 at 2:35 AM
$DOCS I actually sold all my shares at $44.30 on the afternoon run. I was on margin and didn't want to hold too long....100% love this setup though and will look for re-entry on weakness. Good luck.
1 · Reply
Buckanator
Buckanator Dec. 29 at 9:06 PM
$DOCS Strong Base I meant
0 · Reply
Buckanator
Buckanator Dec. 29 at 4:22 PM
$DOCS Strong bad has formed, good entry point
0 · Reply
QuantumQuest
QuantumQuest Dec. 27 at 1:44 PM
$DOCS Capital flows appear selective and reward repeatability; balance‑sheet optionality should not erode — execution across cycles would support multiple expansion. The thesis tightens only when delivery matches ambition.
0 · Reply
TheFedSucks
TheFedSucks Dec. 26 at 11:39 PM
$DOCS seems like a no-brainer entry point.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 25 at 1:34 PM
$DOCS RSI: 20.14, MACD: -2.8916 Vol: 3.26, MA20: 46.41, MA50: 54.19 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
3Henry7
3Henry7 Dec. 20 at 6:00 AM
0 · Reply
Latest News on DOCS
Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript

Nov 6, 2025, 8:56 PM EST - 2 months ago

Doximity, Inc. (DOCS) Q2 2026 Earnings Call Transcript


Doximity Announces Fiscal 2026 Second Quarter Financial Results

Nov 6, 2025, 4:01 PM EST - 2 months ago

Doximity Announces Fiscal 2026 Second Quarter Financial Results


Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript

Aug 7, 2025, 9:50 PM EDT - 5 months ago

Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript


Doximity Acquires Pathway, a Leader in AI Clinical Reference

Aug 7, 2025, 4:02 PM EDT - 5 months ago

Doximity Acquires Pathway, a Leader in AI Clinical Reference


Doximity Announces Fiscal 2026 First Quarter Financial Results

Aug 7, 2025, 4:01 PM EDT - 5 months ago

Doximity Announces Fiscal 2026 First Quarter Financial Results


Doximity: Slowing Sales And EBITDA Growth

Jul 23, 2025, 3:35 PM EDT - 6 months ago

Doximity: Slowing Sales And EBITDA Growth


Doximity Crushes The Rule Of 40 - Try Rule Of 58

Jul 2, 2025, 10:36 AM EDT - 6 months ago

Doximity Crushes The Rule Of 40 - Try Rule Of 58


Doximity Stock 7.8% Higher After Key Trading Signal

May 19, 2025, 7:47 AM EDT - 8 months ago

Doximity Stock 7.8% Higher After Key Trading Signal


These Analysts Cut Their Forecasts On Doximity After Q4 Results

May 16, 2025, 1:51 PM EDT - 8 months ago

These Analysts Cut Their Forecasts On Doximity After Q4 Results


Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript

May 15, 2025, 8:35 PM EDT - 8 months ago

Doximity, Inc. (DOCS) Q4 2025 Earnings Call Transcript


Doximity Stock Drops 20% After Outlook Disappoints

May 15, 2025, 5:55 PM EDT - 8 months ago

Doximity Stock Drops 20% After Outlook Disappoints


Doximity: Rating Downgrade As Near-Term Upside Is Priced In

Feb 14, 2025, 5:53 PM EST - 11 months ago

Doximity: Rating Downgrade As Near-Term Upside Is Priced In


Doximity Momentum, Big Money Support Stays Strong

Feb 14, 2025, 7:49 AM EST - 11 months ago

Doximity Momentum, Big Money Support Stays Strong


Doximity Q3 Earnings: Outpacing Even Management's Expectations

Feb 10, 2025, 12:04 PM EST - 11 months ago

Doximity Q3 Earnings: Outpacing Even Management's Expectations


Doximity shares pop 30% on revenue beat, rosy guidance

Feb 7, 2025, 10:38 AM EST - 11 months ago

Doximity shares pop 30% on revenue beat, rosy guidance


Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 8:01 PM EST - 11 months ago

Doximity, Inc. (DOCS) Q3 2025 Earnings Call Transcript


Doximity Announces Fiscal 2025 Third Quarter Financial Results

Feb 6, 2025, 4:01 PM EST - 11 months ago

Doximity Announces Fiscal 2025 Third Quarter Financial Results


Doximity Q2 Earnings: Positioning Is Paying Off

Nov 15, 2024, 8:00 AM EST - 1 year ago

Doximity Q2 Earnings: Positioning Is Paying Off


Doximity, Inc. (DOCS) Q2 2025 Earnings Call Transcript

Nov 7, 2024, 10:07 PM EST - 1 year ago

Doximity, Inc. (DOCS) Q2 2025 Earnings Call Transcript


StockAnalyst_SA
StockAnalyst_SA Jan. 7 at 9:19 AM
$ONDS – Big Defense Win 🚀 Subscribe for access! It's free 👉 @StockAnalyst_SA (No noise !!) Project: 4M Demining tech part of Israeli MoD multi-layer border system Contract Value: ~$1.7B total Implication: Likely includes Ondas’ recent large border drone order – huge revenue potential ahead $ILMN $ULS $DOCS $AAPL
0 · Reply
11thestate
11thestate Jan. 5 at 2:39 PM
$DOCS has agreed to settle with investors over claims that it misled them by masking declining sales and weaknesses in its healthcare advertising business. Who’s eligible? Anyone who purchased $DOCS shares between July 21, 2021 and August 11, 2022. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? Payout per share has not been determined yet. Can I still file? Claim availability depends on the settlement administrator’s approval process. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/doximity-investor-suit
0 · Reply
SkookBuffett
SkookBuffett Jan. 2 at 5:51 PM
$DOCS may buy back in, question is will it hit a lower low
0 · Reply
TheFedSucks
TheFedSucks Dec. 30 at 2:35 AM
$DOCS I actually sold all my shares at $44.30 on the afternoon run. I was on margin and didn't want to hold too long....100% love this setup though and will look for re-entry on weakness. Good luck.
1 · Reply
Buckanator
Buckanator Dec. 29 at 9:06 PM
$DOCS Strong Base I meant
0 · Reply
Buckanator
Buckanator Dec. 29 at 4:22 PM
$DOCS Strong bad has formed, good entry point
0 · Reply
QuantumQuest
QuantumQuest Dec. 27 at 1:44 PM
$DOCS Capital flows appear selective and reward repeatability; balance‑sheet optionality should not erode — execution across cycles would support multiple expansion. The thesis tightens only when delivery matches ambition.
0 · Reply
TheFedSucks
TheFedSucks Dec. 26 at 11:39 PM
$DOCS seems like a no-brainer entry point.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 25 at 1:34 PM
$DOCS RSI: 20.14, MACD: -2.8916 Vol: 3.26, MA20: 46.41, MA50: 54.19 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
3Henry7
3Henry7 Dec. 20 at 6:00 AM
0 · Reply
jedrzejjj10
jedrzejjj10 Dec. 19 at 5:04 PM
$DOCS I'm starting with my position today. Over the next 60-90 days, I think we could see the stock price rise. A few divergences on 1D. GLTA
0 · Reply
SkookBuffett
SkookBuffett Dec. 18 at 4:27 PM
$DOCS starter
0 · Reply
Borsalino87
Borsalino87 Dec. 17 at 5:39 PM
$DOCS it's time to invest in Doximity. Go with our Hedge Found ! Target : 70/80 $
0 · Reply
StockHunter75
StockHunter75 Dec. 16 at 9:53 PM
$DOCS Buying here
0 · Reply
RunnerSignals
RunnerSignals Dec. 15 at 8:25 PM
$DOCS $MCD $MGM $ORCL $TLRY stock upgrades today with near-term gains possible https://stocksrunner.com/news/2025-12-15-stock-upgrades-today-show-top-picks
0 · Reply
AlphaBull_10M
AlphaBull_10M Dec. 15 at 7:02 PM
$DOCS $CURE $LLY $MRNA leading healthcare today. Just waiting for $UNH to rally to $375+. :-)
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Dec. 15 at 4:27 PM
0 · Reply
DARKP00L
DARKP00L Dec. 15 at 2:30 PM
$DOCS 09:24 on Dec. 15 2025 Doximity shares are trading higher after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $62 to $65. #tradeideas
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Dec. 15 at 1:04 PM
$DOCS Morgan Stanley Upgrades Doximity to Overweight, Raises Price Target to $65
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 1:04 PM
Morgan Stanley has adjusted their stance on Doximity ( $DOCS ), setting the rating to Overweight with a target price of 62 → 65.
0 · Reply
notreload_ai
notreload_ai Dec. 15 at 12:45 PM
$DOCS , $ASAN , $NOW , $AKAM , $ADBE ... Morgan Stanley and KeyBanc updated their views on major tech stocks, upgrading Doximity, Asana, and Akamai, while downgrading ServiceNow and Adobe as part of their 2026 outlook. https://notreload.xyz/analyst-upgrades-and-downgrades-docs-asan-now-akam-adbe/
0 · Reply
theflynews
theflynews Dec. 15 at 10:11 AM
Doximity just upgraded at Morgan Stanley, here's why - $DOCS - https://thefly.com/permalinks/entry.php/DOCSid4256258?1765793113C38
0 · Reply